Belgium treats its first patients with the Integrums tumproteser

PRESS release

2 June 2017

Two patients who received the thumbs amputees were treated at the end of may with the Integrums skelettförankrade implant systems (called opra Implant System). The operations were carried out at the Ghent university hospital (UZ Gent), and is the first thing that is done in Belgium. Thumbs and fingers are an area with good markandspotential then there is a significant population who have lost one or more fingers.

“It is gratifying to see that the sale has now started for our platform for thumbs and fingers. This is an area that has so far been relatively unexploited, but with which we have a CE-marked, standardized system that is ready for scale-up in sales. Through this system we are giving patients the opportunity to regain full functionality and even the ability to experience the sensation again. This is an important step forward in our growth in sales, and we hope that this will get a good spread of both existing and new partners.”, “Jonas Bergman, CEO of Integrum.

Integrums sells today called opra Implant System to the preeminent hospitals the world over, and now intends to accelerate the marketing and sales activities. The demand on the Integrums skelettförankrade implant systems for the thumbs and fingers have also spread to the united states in Integrum has also recently received a “compassionate use” approval from the FDA for the treatment of a tumpatient.


About Integrum AB

Integrum is a medical device company that develops and markets systems for skelettförankrade dentures. With over 400 operations carried out in twelve countries and having worked in the market for almost 20 years, believes the Company will have a leading position in the field. Integrums innovative called opra implant system helps to improve the quality of life for amputees around the world.

For more information, please.v. contact:

Jonas Bergman, CEO

Mobile: 0704 – 18 43 38


Certified Adviser

Erik Penser Bank AB is the Company’s Certified Adviser who can be reached on 08-463 8000.

Belgium treats its first patients with tumproteser – 20170602

Like this post? Please share to your friends:
Leave a Reply